| Literature DB >> 34012462 |
Daniel Zamith-Miranda1,2, Roberta Peres da Silva3, Sneha P Couvillion4, Erin L Bredeweg5, Meagan C Burnet4, Carolina Coelho3, Emma Camacho6, Leonardo Nimrichter7, Rosana Puccia8, Igor C Almeida9, Arturo Casadevall6, Marcio L Rodrigues10,11, Lysangela R Alves10, Joshua D Nosanchuk1,2, Ernesto S Nakayasu4.
Abstract
Extracellular vesicles (EVs) are lipid bilayer structures released by organisms from all kingdoms of life. The diverse biogenesis pathways of EVs result in a wide variety of physical properties and functions across different organisms. Fungal EVs were first described in 2007 and different omics approaches have been fundamental to understand their composition, biogenesis, and function. In this review, we discuss the role of omics in elucidating fungal EVs biology. Transcriptomics, proteomics, metabolomics, and lipidomics have each enabled the molecular characterization of fungal EVs, providing evidence that these structures serve a wide array of functions, ranging from key carriers of cell wall biosynthetic machinery to virulence factors. Omics in combination with genetic approaches have been instrumental in determining both biogenesis and cargo loading into EVs. We also discuss how omics technologies are being employed to elucidate the role of EVs in antifungal resistance, disease biomarkers, and their potential use as vaccines. Finally, we review recent advances in analytical technology and multi-omic integration tools, which will help to address key knowledge gaps in EVs biology and translate basic research information into urgently needed clinical applications such as diagnostics, and immuno- and chemotherapies to fungal infections.Entities:
Keywords: extracellular vesicles; fungi; lipidomics; metabolomics; proteomics; systems biology; transcriptomics; virulence
Year: 2021 PMID: 34012462 PMCID: PMC8126698 DOI: 10.3389/fgene.2021.648524
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
FIGURE 1Comparative lipidomic analysis of H. capsulatum EVs and whole cells. Lipidomics data from previous publications (Burnet et al., 2020; Cleare et al., 2020) of yeast cells grown in F12 medium. Each lipid class was normalized by the total ion intensity of the identified lipid species. Lipid classes significantly (p ≤ 0.05 by Student’s t-test) enriched in extracellular vesicles and whole cells are shown by asterisks and hash signs, respectively. (A) Lipids quantified by mass spectrometry in the positive ionization mode. (B) Lipids quantified by mass spectrometry in the negative ionization mode.
FIGURE 2Comparative proteomic analysis of Histoplasma capsulatum extracellular vesicles and whole cells. Proteomics data from previous publications (Burnet et al., 2020; Cleare et al., 2020) of yeast cells grown in F12 medium. The relative copy number of proteins in cells or extracellular vesicles was calculated using intensity based absolute quantification (iBAQ) by normalizing to the total iBAQ of each sample. Proteins significantly (p ≤ 0.05 by Student’s t-test) enriched in extracellular vesicles (A) and whole cells (B) are indicated as asterisk and hash signs, respectively.
FIGURE 3Comparative transcriptomic analysis of RNA content H. capsulatum extracellular vesicles and whole cells. The expression level is represented as transcripts per million. Transcripts significantly (p ≤ 0.05 by t-test) enriched in extracellular vesicles (A) and whole cells (B) are shown by asterisk and hash signs, respectively.
Effects and virulence factors in fungal EVs.
| Fungus | Virulence factors carried by EVs | |||
| Pathogenesis | Stimulates cytokine production and antifungal activity in macrophages ( | GXM | ||
| (Promotes brain infection) | Enhance adhesion and trans endothelial passage through endothelial cells activating lipid rafts ( | Catalase and superoxide dismutase | ||
| Protection in | Melanin synthesis ( | Urease | ||
| Melanin/laccase | ||||
| nd* | Associated with virulence transference ( | Protein and RNA | ||
| Protection in | Stimulates macrophages to produce NO and cytokines. Stimulates dendritic cells to produce cytokine and up-regulates MHCII and CD86 ( | **SAPs | ***SAPs | |
| Als3 and 4 | Als3 | |||
| Biofilm EVs: | PLB | PLB5 and PLC2 | ||
| Matrix production and biofilm drug resistance ( | ****Ece1p | |||
| Hyphae EVs: | ||||
| Induced TNFα release in THP-1 cells ( | ||||
| Induces adhesion to epithelium and activation of bone marrow-derived dendritic cells ( | Adhesion to epithelial cells | Phosphatase | ||
| Peroxisomal catalase | ||||
| Dendritic cell activation | Superoxide dismutase | |||
| SAP10 | ||||
| Phospholipases B and D | ||||
| Thioredoxin Reductase | ||||
| nd | nd | Phospholipase B | ||
| nd | nd | Lipase (Lip2) | ||
| nd | nd | SAP | ||
| Hwp1-like protein | ||||
| Lysophospholipase | ||||
| nd | Inhibits phagocytosis and killing by macrophages and impacts ROS generation ( | Catalase B, Superoxide Dismutase and a Thiol-specific antioxidant protein | ||
| nd | Induces production of proinflammatory mediators and the M1 polarization of macrophages. | gp43, 14-3-3, PbCdC42, catalase, superoxide dismutase | ||
| Enhance the fungicidal activity of macrophages ( | ||||
| Induces the production of TNF-alpha and CCL-2 by macrophages | Asp F3 and a putative thioredoxin reductase | |||
| Enhances the antifungal activity of macrophages and neutrophils ( | ||||
| Protection in | Induces the production of inflammatory mediators (NO and cytokines) and the M1 polarization of macrophages. Enhance the fungicidal activity of macrophages ( | nd | ||
| Increase in fungal burden and lesion diameter in a mice model of sporotrichosis ( | Enhancement of yeast phagocytosis and fungal burden in dendritic cells. | 70 KDa-glycoprotein | ||
| Increase in cytokine production (IL-12p40 and TNF-alpha; | ||||